[144] CoreWeave, Inc. SEC Filing

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filed a Form 144 notice to sell common stock. The filing reports a proposed sale of 32,455 shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $3,252,640.10 and lists the company's outstanding shares as 370,470,348. The securities were acquired on 02/23/2020 as Series A preferred stock from the issuer. The filing also shows recent 10b5-1 sales on 08/27/2025: 32,455 shares for Michael Intrator (gross proceeds $3,104,307.77) and 50,000 shares for Omnadora Capital LLC (gross proceeds $4,782,480.00). The filer affirms no undisclosed material information and references Rule 10b5-1 trading plans.

Insights

Financial Analyst

TL;DR: Routine insider/Form 144 sale notice showing modest share disposals under 10b5-1; not clearly material to valuation.

The Form 144 discloses a proposed sale of 32,455 common shares valued at $3.25 million and recent 10b5-1 executed sales totaling 82,455 shares with combined gross proceeds shown. Relative to 370.47 million shares outstanding, the volumes are small, suggesting limited direct impact on market supply or per-share valuation. The filing confirms acquisition origin (Series A preferred from issuer) and reliance on trading plans, which supports compliance and reduces signaling ambiguity about timing.

Corporate Governance Expert

TL;DR: Disclosure meets procedural requirements; the use of 10b5-1 plans and the seller's certification reduce governance concerns.

The notice includes the required certifications that no undisclosed material information exists and cites dates for acquisition and prior sales. Use of broker-dealer execution and documented 10b5-1 sales for named parties (Michael Intrator and Omnadora Capital LLC) demonstrates adherence to accepted insider trading controls. From a governance perspective, the filing is a standard transparency disclosure without indication of policy breach.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32455	3252640.10	370470348	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2020	Series A preferred stock	Issuer			32455	02/23/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	32455	3104307.77
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/27/2025	50000	4782480.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CoreWeave (CRWV) disclose?

The Form 144 discloses a proposed sale of 32,455 common shares valued at $3,252,640.10, acquired on 02/23/2020 as Series A preferred stock, to be executed via Morgan Stanley Smith Barney LLC.

Were there recent insider or related-party sales reported for CRWV?

Yes. The filing shows 10b5-1 sales on 08/27/2025: 32,455 shares (Michael Intrator, gross proceeds $3,104,307.77) and 50,000 shares (Omnadora Capital LLC, gross proceeds $4,782,480.00).

How large is the proposed sale relative to outstanding shares?

The proposed 32,455-share sale is small relative to the reported 370,470,348 shares outstanding and therefore is unlikely to materially change share count or immediate market supply.

Does the filing indicate reliance on a trading plan?

Yes. The filing references Rule 10b5-1 sales and includes a representation that the person does not possess undisclosed material information, consistent with trading-plan reliance.

Who is the executing broker for the proposed sale?

The broker listed for the proposed sale is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza.